TAB008

· BioDlink Biopharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAB008, covering 2022-06-22 to 2022-06-22. Get the full timeline:

Most recent: Clinical Trial Update: TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer [Phase 3]